Cite

HARVARD Citation

    Block, G. et al. (2019). The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia. Nephrology dialysis transplantation. 34 (2), pp. 339-346. [Online]. 
  
Back to record